Jump to content

SLA - SILK LASER AUSTRALIA LIMITED


ShareCafe

Recommended Posts

  • Replies 43.2k
  • Created
  • Last Reply

Top Posters In This Topic

  • chiller

    2097

  • diana

    1910

  • Livas1

    4166

  • jezzabot

    2629

Top Posters In This Topic

Posted Images

I see BPO is down again today? is it because somebody knows something we don't? or are they just taking a punt? or is it because if somebody does know something? and the BPO hasn't gone up, they are deducing that if it had been good news, they would have bought? and this has caused someone to sell, because the BPO SP wasn't going up?

if you get my drift as it's long winded?

Link to comment
Share on other sites

In reply to: moosey on Wednesday 27/02/08 03:56pm

moosey there has only been 6 trades in BPO so i wouldnt read anything into the price action today

 

Charles, great to see you are contributing to the bottom line... and its even better to see that now with the increase in chiller family BioA consumption that you can now get your BioA yourself http://www.sharescene.com/html/emoticons/tongue.gifhttp://www.sharescene.com/html/emoticons/biggrin.gif

Link to comment
Share on other sites

QUOTE (Livas1 @ Wednesday 27/02/08 04:03pm)

Your absolutely right Livas,

 

I have been purchasing my own. And guess what, I have discovered that the intermediary I was using before was dudding me, now I only pay around $125 for a six pack instead of $150. http://www.sharescene.com/html/emoticons/mad.gifhttp://www.sharescene.com/html/emoticons/grrr.gifhttp://www.sharescene.com/html/emoticons/thumbdown.gif

 

Cheers Charles

Link to comment
Share on other sites

 

 

For some time now the 'pricing of Ropren' in Russia, and guessing a value, has been a popular discussion point on this site.

 

Somewhere along the line I have not fully grasped the possible importance of this point.

 

My understanding so far is that, in Russia, a price will be set (whether it be $1000, $2,000 or whatever) that hospitals in Russia will be subsidised for putting a patient through a course of Ropren treatment. The subsidy will be provided to cover the full treatment ( eg.medical staff, accommodation,Ropren) and not just for the Ropren.

 

I have not read anywhere that Solagran is restricted to operating within this proposed figure.

 

So, with the pent up demand that appears to be there surely Solagran can still name their own price to sell Ropren in Russia and it is up to the hospitals to recoup any difference in price from the patient.

 

Does the Russian hospital system operate in a manner that provides full care at no cost to any citizen?

 

Is it a case that the drug price must not exceed its portion value of the subsidised figure?

 

Could someone please enlighten me on what I am missing.

 

 

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now

×
×
  • Create New...